Allegan, Michigan based Private Brand manufacturer of OTC pharmaceutical products and infant formulas Perrigo announced that it has begun shipping Loratadine-D 12 hour extended release tablets, the store brand equivalent to Schering-Plough’s Claritin-D 12 hour extended release tablets.
Claritin-D 12 is indicated for the treatment of nasal allergy symptoms. Its estimated annual sales are approximately $111 million, according to data provided by Wolters, Kluwer.
Perrigo’s Chairman and CEO Joseph C. Papa stated, “This launch is another milestone for our Consumer Healthcare segment, which is expected to launch many important new store brand products during this fiscal year. We are excited to bring this important store brand medication to consumers for the first time and continue our focus on making quality healthcare more affordable.”